Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of CITicoline (TRAUSAN) in Preventing Cognitive Decline After DELirium in Older Adults With Proximal Hip Fracture - The CITADEL Randomized Controlled Trial

NCT07804498 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT07804498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07804498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of CITicoline (TRAUSAN) in Preventing Cognitive Decline After DELirium in Older Adults With Proximal Hip Fracture - The CITADEL Randomized Controlled Trial
Lead sponsor
University of Milano Bicocca
Phase
Phase 2
Overall status
Recruiting
Start date
June 3, 2026
Completion date
December 5, 2027
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, delirium